TherapeuticsMD, Inc. – NASDAQ:TXMD
Founder-led company
TherapeuticsMD stock price today
$1.11
+0.02
+1.83%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 2 hours
TherapeuticsMD stock price monthly change
-41.08%
month
TherapeuticsMD stock price quarterly change
-41.08%
quarter
TherapeuticsMD stock price yearly change
-54.39%
year
TherapeuticsMD key metrics
Market Cap | 12.23M |
Enterprise value | 109.26M |
P/E | -3.44 |
EV/Sales | 1.24 |
EV/EBITDA | 4.81 |
Price/Sales | 0.38 |
Price/Book | -0.70 |
PEG ratio | -0.51 |
EPS | -0.70 |
Revenue | 1.19M |
EBITDA | -5.50M |
Income | -7.40M |
Revenue Q/Q | -24.75% |
Revenue Y/Y | -97.65% |
Profit margin | -9.9% |
Oper. margin | -115.68% |
Gross margin | 79.28% |
EBIT margin | -115.68% |
EBITDA margin | -459.3% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTherapeuticsMD stock price history
TherapeuticsMD stock forecast
TherapeuticsMD financial statements
| Jun 2023 | 437K | -2.41M | -552.4% |
|---|---|---|---|
| Sep 2023 | -53K | -3.37M | 6373.58% |
| Dec 2023 | 502K | -883K | -175.9% |
| Mar 2024 | 313K | -734K | -234.5% |
| 2027 | 9.5M | 1.98M | 20.88% |
|---|
Analysts Price target
Financials & Ratios estimates
| 2022-08-15 | -50.49792 | 12.39 |
|---|---|---|
| 2022-11-14 | -17.18746 | -3.13 |
| 2023-03-27 | -1.11 | -4.5 |
| Jun 2023 | 53689000 | 22.49M | 41.89% |
|---|---|---|---|
| Sep 2023 | 50493000 | 22.44M | 44.44% |
| Dec 2023 | 43309000 | 14.02M | 32.38% |
| Mar 2024 | 42088000 | 13.42M | 31.9% |
| Jun 2023 | -3.39M | 0 | 1.15M |
|---|---|---|---|
| Sep 2023 | -6.02M | 0 | -1K |
| Dec 2023 | -7.84M | 0 | 2.00M |
| Mar 2024 | 11K | 0 | 0 |
TherapeuticsMD alternative data
| Aug 2023 | 1 |
|---|---|
| Sep 2023 | 1 |
| Oct 2023 | 1 |
| Nov 2023 | 1 |
| Dec 2023 | 1 |
| Jan 2024 | 1 |
| Feb 2024 | 1 |
| Apr 2024 | 1 |
| May 2024 | 1 |
| Jun 2024 | 1 |
| Jul 2024 | 1 |
TherapeuticsMD other data
20.63%
-16.90%
of TXMD is owned by hedge funds
25
-19
1.93M
-1.54M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2023 | 0 | 3006 |
| Apr 2023 | 0 | 1862 |
| Dec 2023 | 0 | 19050 |
| Patent |
|---|
Grant Filling date: 17 Jan 2020 Issue date: 19 Apr 2022 |
Grant Filling date: 7 Dec 2016 Issue date: 8 Mar 2022 |
Application Filling date: 29 Oct 2021 Issue date: 17 Feb 2022 |
Grant Filling date: 8 Nov 2019 Issue date: 15 Feb 2022 |
Application Filling date: 15 Jun 2021 Issue date: 10 Feb 2022 |
Grant Filling date: 27 Mar 2020 Issue date: 8 Feb 2022 |
Application Filling date: 7 Dec 2016 Issue date: 20 Jan 2022 |
Grant Filling date: 16 Aug 2018 Issue date: 9 Nov 2021 |
Grant Filling date: 1 Apr 2020 Issue date: 21 Sep 2021 |
Grant Filling date: 1 Apr 2020 Issue date: 14 Sep 2021 |
| Quarter | Transcript |
|---|---|
| Q2 2022 15 Aug 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 16 May 2022 | Q1 2022 Earnings Call Transcript |
| Q3 2021 11 Nov 2021 | Q3 2021 Earnings Call Transcript |
| Q2 2021 4 Aug 2021 | Q2 2021 Earnings Call Transcript |
TherapeuticsMD: Privatization Deal Expected To Meet With Shareholder Pushback
TherapeuticsMD: Looking For A Potential Turnaround After Divesting VitaCare Business
TherapeuticsMD: Time For Bulls To Take A Contrarian Approach
TherapeuticsMD: The Long Road To Profitability
TherapeuticsMD: Fighting To Regain Support Above $1.20
TherapeuticsMD: Great Product, But We Are Underwhelmed By Execution
-
What's the price of TherapeuticsMD stock today?
One share of TherapeuticsMD stock can currently be purchased for approximately $1.11.
-
When is TherapeuticsMD's next earnings date?
Unfortunately, TherapeuticsMD's (TXMD) next earnings date is currently unknown.
-
Does TherapeuticsMD pay dividends?
No, TherapeuticsMD does not pay dividends.
-
How much money does TherapeuticsMD make?
TherapeuticsMD has a market capitalization of 12.23M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 98.14% to 1.3M US dollars. TherapeuticsMD made a loss 10.28M US dollars in net income (profit) last year or -$4.5 on an earnings per share basis.
-
What is TherapeuticsMD's stock symbol?
TherapeuticsMD, Inc. is traded on the NASDAQ under the ticker symbol "TXMD".
-
What is TherapeuticsMD's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of TherapeuticsMD?
Shares of TherapeuticsMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are TherapeuticsMD's key executives?
TherapeuticsMD's management team includes the following people:
- Mr. Robert G. Finizio Co-Founder & Vice Chair(age: 54, pay: $1,220,000)
- Mr. John C. K. Milligan IV Chief Executive Officer of VitaCare Prescription Services(age: 63, pay: $796,280)
- Dr. Brian A. Bernick Co-Founder & Chief Scientific Officer(age: 57, pay: $96,610)
-
Is TherapeuticsMD founder-led company?
Yes, TherapeuticsMD is a company led by its founders Mr. Robert G. Finizio and Dr. Brian A. Bernick.
-
How many employees does TherapeuticsMD have?
As Jul 2024, TherapeuticsMD employs 1 workers.
-
When TherapeuticsMD went public?
TherapeuticsMD, Inc. is publicly traded company for more then 18 years since IPO on 9 May 2007.
-
What is TherapeuticsMD's official website?
The official website for TherapeuticsMD is therapeuticsmd.com.
-
Where are TherapeuticsMD's headquarters?
TherapeuticsMD is headquartered at 951 Yamato Road, Boca Raton, FL.
-
How can i contact TherapeuticsMD?
TherapeuticsMD's mailing address is 951 Yamato Road, Boca Raton, FL and company can be reached via phone at +56 19611900.
TherapeuticsMD company profile:
TherapeuticsMD, Inc.
therapeuticsmd.comExchange:
NASDAQ
Full time employees:
1
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
951 Yamato Road
Boca Raton, FL 33431
Boca Raton, FL 33431
CIK: 0000025743
ISIN: US88338N2062
CUSIP: 88338N206
